John McMurray
The VALIANT trial compared ACE-inhibitor, ARB and a combination of the two in high-risk post-MI patients, and found there may be an interaction between them and statins. John McMurray from the Western Infirmary in Glasgow.
[audio:https://www.audiomedica.com/podcasting/aha2005/John_McMurray.mp3]